Coya Therapeutics Inc — Cash Flow (NASDAQ:COYA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -7.24 M-11.19 M-10.29 M-10.74 M -10.74 M Cash from investing activities -525 K-543.19 K-25 K-1.16 M — Cash from financing activities 9.36 M38.43 M16.03 M20.39 M 20.39 M Free cash flow -7.24 M-11.19 M-10.29 M-10.74 M -10.74 M

News

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts - TipRanks.com

Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock?

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target

Coya Therapeutics secures $11.1 million in private placement

Coya Therapeutics advances ALS and FTD clinical trials in 2026

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18

Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock

H.C. Wainwright reaffirms Buy rating on Coya Therapeutics stock at $18 target

Coya Therapeutics closes $23 million public offering of common stock

Coya Therapeutics stock falls after pricing $20 million public offering

Coya Therapeutics prices $20 million public offering of common stock